Xueran Guo

Risk factors and predictors for botulinum toxin type A reinjection within six months in patients with acute acquired concomitant esotropia

BACKGROUND: To identify independent risk factors and predictors for botulinum toxin type A (BTA) reinjection within 6 months in acute acquired concomitant esotropia (AACE) patients, providing a scientific foundation for risk-stratified clinical management. METHODS: In this case-c...